Found: 8
Select item for more details and to access through your institution.
Correction to: CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.
- Published in:
- Journal of NeuroVirology, 2018, v. 24, n. 1, p. 98, doi. 10.1007/s13365-017-0600-6
- By:
- Publication type:
- Article
Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: are concentrations required clinically achievable?
- Published in:
- 2021
- By:
- Publication type:
- Letter
Elvitegravir concentrations in seminal plasma in HIV-1-infected men.
- Published in:
- HIV Medicine, 2017, v. 18, n. 3, p. 225, doi. 10.1111/hiv.12417
- By:
- Publication type:
- Article
Viral response in stable patients switching to fosamprenavir/ritonavir monotherapy (the FONT Study)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Viral response in stable patients switching to fosamprenavir/ritonavir monotherapy (the FONT Study).
- Published in:
- HIV Medicine, 2011, v. 12, n. 7, p. 438, doi. 10.1111/j.1468-1293.2010.00898.x
- By:
- Publication type:
- Article
Successful outcome of ganciclovir-resistant cytomegalovirus infection in organ transplant recipients after conversion to mTOR inhibitors.
- Published in:
- Transplant International, 2012, v. 25, n. 7, p. e78, doi. 10.1111/j.1432-2277.2012.01489.x
- By:
- Publication type:
- Article
Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics.
- Published in:
- Transplant Infectious Disease, 2010, v. 12, n. 3, p. 204, doi. 10.1111/j.1399-3062.2009.00481.x
- By:
- Publication type:
- Article